Corix Bioscience (Corix Bioscience) Interest Expense : $-0.64 Mil (TTM As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Corix Bioscience's interest expense for the three months ended in Sep. 2017 was $ -0.24 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2017 was $-0.64 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Corix Bioscience's Operating Income for the three months ended in Sep. 2017 was $ -0.30 Mil. Corix Bioscience's Interest Expense for the three months ended in Sep. 2017 was $ -0.24 Mil. Corix Bioscience did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Corix Bioscience Interest Expense Historical Data

The historical data trend for Corix Bioscience's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Interest Expense Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

Interest Expense

Get a 7-Day Free Trial

-0.39

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Interest Expense	Get a 7-Day Free Trial															-	-0.39	-	-0.02	-0.24

Corix Bioscience Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.64 Mil.

Corix Bioscience (GREY:CXBS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Corix Bioscience's Interest Expense for the three months ended in Sep. 2017 was $-0.24 Mil. Its Operating Income for the three months ended in Sep. 2017 was $-0.30 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2017 was $0.00 Mil.

Corix Bioscience's Interest Coverage for the quarter that ended in Sep. 2017 is calculated as

Corix Bioscience did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines